SGX Pharmaceuticals , Nasdaq: SGXP
A biotechnology company developing novel cancer therapeutics.
Industry: Health Care
First Day Return: 0.0%
Industry: Health Care
SGXP
A biotechnology company developing novel cancer therapeutics.
| IPO Data | |
|---|---|
| IPO File Date | 09/02/2005 |
| Offer Price | $6.00 |
| Price Range $11.00 - $13.00 | |
| Offer Shares (mm) | 4.0 |
| Deal Size ($mm) | $24 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 01/31/2006 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $24 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | San Diego, CA, United States |
| Founded | 1998 |
| Employees at IPO | n/a |
| Website www.sgxpharma.com | |
IPO News for SGX Pharmaceuticals
SGX Pharmaceuticals (SGXP) Performance
